Maybe More Is Better-Reference-Cited by-同舟云学术

Maybe More Is Better

Published:2003-07-01 Issue:13 Volume:21 Page:2454-2456
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Thigpen Tate¹

Affiliation:

1. Division of Oncology, University of Mississippi Medical Center, Jackson, MS

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.93.115

Reference18 articles.

1. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.

2. Importance of Multiagent Chemotherapy Regimens in Ovarian Carcinoma: Dose Intensity Analysis

3. Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.

4. Colombo N, Pittelli M, Parma G, et al: Cisplatin dose intensity in advanced ovarian cancer: A randomized study of conventional dose versus dose-intense cisplatin monochemotherapy. Proc Am Soc Clin Oncol 12:255,1993, (abstr 806)

5. High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing cancer pharmacotherapeutics using mathematical modeling and a systems biology approach;Personalized Medicine;2011-05

2. Living with Cancer: Perspectives on a Five Year Journey;Nursing Clinics of North America;2010-09

3. Current treatment and clinical trials in ovarian cancer;Expert Opinion on Investigational Drugs;2010-03-31

4. Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization;Computers & Chemical Engineering;2009-12

5. Maintenance or Consolidation Therapy in Advanced Ovarian Cancer;Oncology;2006